219
(750 mg, 0.9 mmol) in HF–pyridine (5 mL, 7:3 v/v ) was mmol) was de-O-acylated in methanol (100 mL) at 0 °C by
stirred at 0 °C for 1 h in a plastic vial. The mixture was diluted successive additions of sodium methoxide (1 M, 500 µL ) over
with CH2Cl2 and poured into ice-cold aqueous NH3 (3 M), the 30 h. The mixture was neutralized with Amberlite IR 120 (H+)
organic layer was washed with saturated aqueous NaHCO3 resin, the resin was removed by filtration and the filtrate was
(3×), dried, and concentrated. Flash chromatography (EtOAc– concentrated. The free fluoride 1 was dissolved with the mini-
petroleum ether 1:1 v/v) gave compound 5, which crystallized mum of H2O, washed with Et2O to remove the methyl ben-
in EtOH (675 mg, 94%); mp 134 °C; [α]25 +31 (c 0.73, zoate, and freeze dried (580 mg, 89%); FABMS: m/z 451 [M +
D
CHCl3); 13C NMR (CDCl3, 75 MHz) δ 170.0–160.5 (CO), Na]+.
133.6 (Cq arom.), 129.6–128.9 (CH arom.), 103.5 (d, JC,F
=
230 Hz, C-1I), 100.6 (C-1II), 75.4, 72.2, 72.0, 71.6, 71.3, 70.5,
70.3, 70.0, 68.5 (C-2I,II, C-3I,II, C-4I,II, C-5I,II), 61.9, 60.8 (C-
General procedure for the enzymatic reactions
THP fluoride 1 (0.23 mmol) and acceptors (1 equiv) in
carbonate/bicarbonate buffer (0.1 M, pH 10, 5 mL) were incu-
bated with Cel7B E197A (1.5 mg) for 15 h at 40 °C. The
solution was diluted with H2O to make the reaction product
soluble and 1 M HCl (1–2 drops) was added. After 5 min at pH
1–2, the solution was neutralized with Et3N, concentrated to
dryness, and acetylated (acetic anhydride–pyridine 1:1 v/v, 10
mL). After 12 h of stirring at 25 °C, the reaction was quenched
at 0 °C by addition of MeOH and concentrated. The residue
was dissolved in CH2Cl2 and washed with 20% aqueous
KHSO4 and saturated aqueous NaHCO3. The organic layers
were dried, concentrated, and purified by flash chromatogra-
phy (EtOAc–petroleum ether 7:3 v/v) to give methyl β-
cellotrioside 10a (78%), methyl β-cellotetraoside 11a (90%),
methyl β-cellopentaoside 12 (83%) or methyl β-
cellohexaoside 13 (60%). The NMR and mass spectra were in
accordance with those recently described in the literature.4
1
6I,II), 20.7–20.3 (CH3); H NMR (CDCl3, 300 MHz) δ 7.60–
7.43 (m, 5H, H arom.), 5.65 (dd, 1H, J1,2 = 3 Hz, J1,F = 53 Hz,
H-1I), 5.45-5.25 (m, 3H), 4.97 (t, 1H, J = 9 Hz), 4.80 (dd, 1H,
J = 3 and 10 Hz), 4.63–4.52 (m, 3H including H-1II), 4.38 (dd,
1H, J = 4.5 and 12.5 Hz), 4.12–4.04 (m, 2H), 3.95 (m, 1H),
3.80 (t, 1H, J = 10 Hz), 2.08–1.87 (m, 15H, CH3); Anal. Calcd
for C31H34Cl3FO17: C, 46.31; H, 4.26; Cl, 13.23; F, 2.36.
Found: C, 46.46; H, 4.02; Cl, 13.22; F, 2.22.
(2,3-Di-O-acetyl-6-O-benzoyl-β-D-glucopyranosyl)-
(1→4)-2,3,6-tri-O-acetyl-α-D-glucopyranosyl fluoride (6). To
a solution of fluoride 5 (1.19 g, 1.48 mmol) in DMF (5 mL) at
50 °C, hydrazine acetate (136 mg, 1 equiv) was added every 5
min until the total transformation of the starting material. The
solution was then diluted with EtOAc, washed with saturated
aqueous NaCl, dried, concentrated, and purified by flash chro-
matography (EtOAc–petroleum ether 7:3 v/v) to give pure
compound 6 (855 mg, 88%); [α]25 +18 (c 0.87, CHCl3);
Methyl (2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-
(1→4)-(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→4)-2,3,6-
tri-O-acetyl-β-D-glucopyranoside (10a). 13C NMR (CDCl3, 75
MHz) δ 170.3–168.9 (CO), 101.2, 100.6, 100.3 (C-1I–III), 76.3,
D
13C NMR (CDCl3, 75 MHz) δ 170.0–166.8 (CO), 133.5 (Cq
arom.), 129.6–128.5 (CH arom.), 103.5 (d, JC,F = 230 Hz,
C-1I), 100.7 (C-1II), 75.4, 74.2, 71.5, 70.7, 70.6, 70.4, 70.0,
68.7, 68.4 (C-2I,II, C-3I,II, C-4I,II, C-5I,II), 63.1, 61.0 (C-6I,II),
20.6–20.4 (CH3); 1H NMR (CDCl3, 300 MHz) δ 8.01–7.42 (m,
5H, H arom.), 5.62 (d, 1H, J1,2 = 2.5 Hz, J1,F = 53 Hz, H-1I),
5.41 (t, 1H, J = 9.5 Hz), 5.0 (t, 1H, J = 9 Hz), 4.87–4.81 (m,
1H), 4.77 (dd, 1H, J = 3 and 10 Hz), 4.65 (dd, 1H, J = 3.7 and
12 Hz), 4.53 (m, 3H), 4.14–4.02 (m, 3H), 3.79 (t, 1H, J = 10
Hz), 3.65 (m, 1H), 2.06–1.94 (m, 15H, CH3); DCIMS: m/z 676
[M + H + NH3]+; Anal. Calcd for C29H35FO16: C, 52.89; H,
5.36; F, 2.88. Found: C, 53.15; H, 5.52; F, 2.68.
76.0, 72.7, 72.5, 72.4, 71.8, 71.7, 71.5, 67.7 (C-2I–III, C-3I–III
,
C-4I–III, C-5I–III), 62.0, 61.6, 61.4 (C-6I–III), 56.7 (OCH3), 20.6–
20.3 (CH3); DCIMS: m/z 956 [M + H+ NH3]+.
Methyl (2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-
(1→4)-(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→4)-
(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→4)-2,3,6-tri-O-
acetyl-β-D-glucopyranoside (11a). 13C NMR (CDCl3, 75
MHz) δ 169.5–168.9 (CO), 101.3, 100.6, 100.3 (C-1I–IV), 76.3,
76.1, 76.0, 72.8, 72.6, 72.3, 71.9, 71.8, 71.6, 71.5 67.7 (C-2I–IV
,
C-3I–IV, C-4I–IV, C-5I–IV), 62.0, 61.7, 61.4 (C-6I–IV), 56.8
(2,3-Di-O-acetyl-6-O-benzoyl-4-O-tetrahydropyranyl-β-
D -glucopyranosyl)-(1→4)-2,3,6-tri-O-acetyl-α-D -
glucopyranosyl fluoride (7). To a solution of compound 6
(1.02 g, 1.56 mmol) in CH2Cl2 (10 mL) were added freshly
distilled dihydropyran (680 µL, 5 equiv) and camphorsulfonic
acid (24 mg, 0.07 equiv). After 1 h at room temperature, the
solution was diluted with CH2Cl2 and successively washed
with H2O and saturated aqueous NaHCO3. The organic layer
was dried, concentrated and purified by flash chromatography
(EtOAc–petroleum ether 1:1 v/v) to give compound 7, which
crystallized in EtOH (1.13 g, 98%); mp 140 °C; [α]25D +25 (c
1.05, CHCl3); FABMS: m/z 765 [M + Na]+; Anal. Calcd for
C34H43FO17: C, 54.98; H, 5.84; F, 2.56. Found: C, 55.11; H,
6.15; F, 2.46.
(OCH3), 20.9–20.4 (CH3); FABMS: m/z 1250 [M + Na]+
Methyl β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyl-
(1→4)-β-D-glucopyranoside (10b) and Methyl β-D-gluco-
pyranosyl-(1→4)-β-D-glucopyranosyl-(1→4)-β-D-gluco-
pyranosyl-(1→4)-β-D-glucopyranoside (11b). They were ob-
tained by Zemplèn de-O-acetylation of compounds 10a and
11a with 1 M sodium methoxide (1% v/v in MeOH), neutral-
ization with Amberlite IR 120 (H+) resin, and concentration.
Methyl (2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-
(1→4)-(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→4)-
(2,3,6-tri-O-acetyl-β-D-glucopyranosyl)-(1→4)-(2,3,6-tri-O-
acetyl-β-D-glucopyranosyl)-(1→4)-2,3,6-tri-O-acetyl-β-D-
glucopyranoside (12). 13C NMR (CDCl3, 75 MHz) δ 169.5–
169.3 (CO), 101.7, 101.0, 100.7 (C-1I–V), 76.7, 76.4, 76.3,
73.1, 73.09, 72.99, 72.9, 72.8, 72.7, 72.3, 72.16, 72.06, 71.87,
(4-O-Tetrahydropyranyl-β-D-glucopyranosyl)-(1→4)-α-
D-glucopyranosyl fluoride (1). The fluoride 7 (1.13 g, 1.5
Fort et al. / Enzymatic Synthesis of Cellodextrins